# BioStem Life Sciences – FDA Inspection, Sep 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/biostem-life-sciences/de55e7e3-8385-47a6-a7e2-115a7f378976
Source feed: FDA_Inspections

> FDA inspection 1219616 of BioStem Life Sciences, September 15, 2023. Classification: Official Action Indicated (OAI). 6 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219616
- Company Name: BioStem Life Sciences
- Inspection Date: 2023-09-15
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 6

## Related Documents

- FDA Inspection 1291328 - 2025-09-26
- [FDA Inspection 1055502 - 2018-06-13](https://www.keypedia.com/records/fda_inspections/biostem-life-sciences/083c516d-ed06-4889-a482-5bcc6361e7fe)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/annette-melendez/bc1a065d-6408-4c4b-9dcf-c6884e8a75c4)
- [Issuing Officer](https://www.keypedia.com/people/ivan-e-reyes/69bac3eb-f63c-45f0-8420-85a7e06b884a)
- [Issuing Officer](https://www.keypedia.com/people/sergio-e-delgado/5edfee62-05aa-44aa-9161-def8f31d3ea2)

Company: https://www.keypedia.com/companies/biostem-life-sciences/8bd5184b-7fa5-4821-8bdd-5fae8be6fe62

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d